SpaceX IPO may allocate 30% to retail investors—triple the typical amount. Banks prepare for $1.75T valuation as filing expected within weeks.
Browsing: Stocks
The Nasdaq enters correction territory with an 11% drop from October highs as Iran war uncertainty, rising energy costs, and tech stock weakness weigh on markets.
Norwegian Cruise Line (NCLH) stock declines despite Elliott Investment Management board deal, as rising fuel costs continue to pressure shares downward.
Target (TGT) faces boycott from 1.8M-member teachers union over response to ICE enforcement in Minneapolis, complicating its turnaround efforts.
Citi keeps S&P 500 target at 7,700 despite Iran conflict and tariff risks. Bank sees $320 earnings for 2026, now viewed as conservative estimate.
Alphabet (GOOGL) fell 7% this week after a legal ruling, but Wells Fargo raised its price target to $397, citing AI chips and Wiz acquisition as catalysts.
Wedbush maintains $350 target on Apple (AAPL), citing 38% upside potential driven by iPhone Fold launch, AI-powered Siri upgrades, and robust 2026 roadmap.
Jim Cramer analyzes Nvidia (NVDA) stock amid Iran conflict concerns. Wells Fargo sees potential upside beyond the company’s $1T data center revenue target.
Five growth stocks including Cloudflare (NET), MercadoLibre (MELI), and Nu Holdings (NU) could be undervalued based on evolving business models and earnings.
Meta (META) stock dropped 8% after court losses. The company increased its El Paso AI data center investment from $1.5B to $10B—a sixfold jump.
Amazon (AMZN) stock dropped 2% after Gadi Hutt, a director at Annapurna Labs, left the company—the second senior AI chip executive to depart in seven months.
Anthropic’s Claude Mythos AI model was exposed through a data breach, revealing advanced cyber capabilities and the company’s October 2026 IPO plans.
Nvidia (NVDA) now trades at a 19.7x forward P/E, below the S&P 500’s 20.3x—the first discount in 13 years. What this means for investors.
Revolution Medicines (RVMD) sees executive sell $3.5M in stock amid analyst upgrades to strong-buy and surging institutional ownership at 94%.
Argan (AGX) stock rallied 10% after Q4 EPS of $3.47 beat estimates by $1.34. Backlog hit $2.9B and FY27 guidance exceeded Wall Street expectations.